| |
| |
|
| Insider
Information: |
Platt David |
| Relationship: |
CEO, Director, 10% Owner |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
46,736,274 |
|
|
Indirect Shares
|
20,133,018 |
|
|
| Direct
Value |
$10,020,000 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
66,869,292 |
|
|
| Total
Value |
$10,020,000 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Glycogenesys Inc |
GLGSQ |
Affiliate |
2003-08-27 |
709,000 |
2003-07-07 |
0 |
Premium* |
|
|
Galectin Therapeutics Inc |
GALT |
Chairman & CEO, Director |
2008-01-16 |
3,000,000 |
2008-01-16 |
0 |
Premium* |
|
|
US Rare Earth Minerals |
USMND |
CEO, Director, 10% Owner |
2021-11-19 |
43,027,274 |
2024-03-27 |
20,133,018 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| USMND |
US Rare Earth Minerals |
CEO |
• • • |
2024-03-27 |
4 |
A |
$0.10 |
$45,718 |
I/I |
439,595 |
20,133,018 |
0 |
- |
|
| USMND |
US Rare Earth Minerals |
CEO |
• • • |
2024-01-16 |
4 |
A |
$0.14 |
$485,904 |
I/I |
3,599,289 |
19,693,423 |
0 |
- |
|
| USMND |
US Rare Earth Minerals |
CEO |
• • • |
2023-09-14 |
4 |
A |
$0.14 |
$786,340 |
I/I |
5,824,741 |
16,094,134 |
0 |
- |
|
| USMND |
US Rare Earth Minerals |
CEO |
• • • |
2023-08-21 |
4 |
GA |
$0.32 |
$160,000 |
I/I |
500,000 |
10,269,393 |
0 |
- |
|
| USMND |
US Rare Earth Minerals |
CEO |
• • • |
2023-05-17 |
4 |
GD |
$0.32 |
$29,440 |
I/I |
92,000 |
19,535,300 |
0 |
- |
|
| USMND |
US Rare Earth Minerals |
CEO |
• • • |
2023-04-14 |
4 |
A |
$0.32 |
$2,164,340 |
I/I |
6,763,562 |
10,861,393 |
0 |
- |
|
| USMND |
US Rare Earth Minerals |
CEO |
• • • |
2022-11-21 |
4 |
GD |
$0.00 |
$1,234 |
I/I |
411,300 |
2,197,565 |
0 |
- |
|
| USMND |
US Rare Earth Minerals |
CEO, Chairman |
• • • |
2022-08-16 |
4 |
|
$0.00 |
$456 |
I/I |
455,669 |
45,962,806 |
0 |
- |
|
| USMND |
US Rare Earth Minerals |
CEO |
• • • |
2021-12-03 |
4 |
A |
$0.00 |
$4,137 |
I/I |
2,068,563 |
2,068,563 |
0 |
- |
|
| USMND |
US Rare Earth Minerals |
CEO |
• • • |
2021-11-19 |
4 |
GD |
$0.14 |
$441,847 |
D/D |
3,201,788 |
43,027,274 |
0 |
- |
|
| USMND |
US Rare Earth Minerals |
CEO |
• • • |
2021-06-04 |
4 |
A |
$0.13 |
$386,618 |
D/D |
2,973,988 |
46,229,062 |
0 |
- |
|
| USMND |
US Rare Earth Minerals |
CEO |
• • • |
2021-01-15 |
4 |
A |
$0.24 |
$54,672 |
D/D |
227,800 |
43,255,074 |
0 |
- |
|
| USMND |
US Rare Earth Minerals |
CEO |
• • • |
2020-01-07 |
4 |
GD |
$0.00 |
$865 |
D/D |
864,700 |
43,027,274 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chairman & CEO |
• • – |
2008-10-08 |
4 |
B |
$0.00 |
$0 |
D/D |
6,000 |
6,000 |
2.73 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chairman & CEO |
• • – |
2008-09-18 |
4/A |
B |
$0.20 |
$5,260 |
D/D |
26,300 |
26,300 |
2.81 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chairman & CEO |
• • – |
2008-09-18 |
4 |
B |
$0.23 |
$230 |
D/D |
1,000 |
1,000 |
2.73 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chairman & CEO |
• • – |
2008-04-01 |
4 |
B |
$0.00 |
$0 |
D/D |
5,667 |
5,667 |
2.73 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chairman & CEO |
• • – |
2008-01-16 |
5 |
GD |
$0.00 |
$0 |
I/I |
327,468 |
0 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chairman & CEO |
• • • |
2007-11-30 |
5 |
GD |
$0.00 |
$0 |
I/I |
400,000 |
0 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chairman & CEO |
• • • |
2007-08-28 |
5 |
GD |
$0.00 |
$0 |
I/I |
400,000 |
0 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chairman & CEO |
• • • |
2007-06-19 |
5 |
GD |
$0.00 |
$0 |
I/I |
200,000 |
0 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chairman & CEO |
• • • |
2007-06-04 |
5 |
GD |
$0.00 |
$0 |
I/I |
200,000 |
0 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chairman & CEO |
• • • |
2006-06-08 |
4 |
AS |
$3.75 |
$16,500 |
D/D |
(4,400) |
0 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chairman & CEO |
• • • |
2004-06-24 |
5 |
GD |
$0.00 |
$0 |
I/I |
5,000 |
1,090,000 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chairman & CEO |
• • • |
2004-04-13 |
5 |
GD |
$0.00 |
$0 |
D/D |
3,441,868 |
0 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
